retatrutide triple agonist glp1 gip glucagon Beyond GLP-1: Retatrutide's triple-agonist mechanism (GLP-1, GIP, glucagon) is redefining metabolic health. Phase 2 data shows ~24% weight loss—surpassing semaglutide & tirzepatide. Evidence-based protocols demand nutrition support alongside prescribing Retatrutide: The GLP-1/GIP/Glucagon Triple-Agonist Guide

Astaxanthin A carotenoid antioxidant 6,000x more potent than Vitamin C by singlet oxygen quenching capacity

From acting against tumors to modulating the immune response, they exemplify the deep interconnection between our gut environment and overall health

Additionally, cooking often destroys the glutathione in food, making high-quality supplementation a more effective choice for targeted goals

Med Clin North Am 2021;105:117

Effects of abnormal NAD+ metabolism in the TCA cycle on oocytes As a hub of energy metabolism and ageing-related signalling pathways, the attenuation of TCA cycle activity is closely related to age-related metabolic disorders, thus becoming an important molecular target for antiaging interventions [80]

The MDL focuses specifically on gastrointestinal injury claims related to GLP-1 drugs including Ozempic, Wegovy, Rybelsus, Trulicity, and Mounjaro